Member Info for justdeezerts

TwoGood speculating out of his wrong end, as usual.

CFO has gone (or pushed out) after being at the helm during a period where cash pile has diminished substantially and SP has crashed spectacularly. Why would investors be sorry to see a change in financial leadership?

I'd say it is a plus and Simon Sitwell has decided to show confidence by leading from the front - IMHO.

Cashking - the rantings of the ill-informed and mischievous!

Just check other BBs, where this name has made contributions......

Troajan - good find on Proactive, thanx.

JS explains the recent Directors' small buys - makes total sense. He also addressed the ridiculous divergence between the current SP and Directors' assessment of ITX's true potential value.

Some comfort for LTHs.

A Healthy and Prosperous and Peaceful 2024 to all on this BB.

IWantThatOne - you have it wrong here!

Read MorningStar article on Labour's ill-judged scheme:

"Reducing waiting times through funding additional overtime, as Streeting proposes, is an uncertain strategy which could exacerbate staffing problems.

Many doctors and nurses report hospitals struggling to maintain safe staffing levels on weekdays. Given that, looking to extra weekend shifts to address an operations backlog is hardly a sustainable solution.

Doctors and nurses already work weekends. Normalising weekend work for routine rather than urgent care is anti-social, further disrupting work-life balance in a sector where most will be giving up a large number of weekends already — something of particular concern to staff with families and likely in practice to hit female workers hardest.

Cash-strapped hospital trusts, juggling costs from PFI debt to medicines, may seek to normalise weekend working as an expectation rather than pay overtime premiums.

And the NHS, with its 100,000-plus staffing vacancies, has a limited pool to draw overtime labour from. Had Labour spent more time listening to the voices of doctors, nurses and paramedics on picket lines this year rather than ordering MPs not to attend them, it would have clocked concerns about burnout alongside those about pay: health workers terrified of making mistakes because they are working while exhausted and hungry, unable to take breaks because there are too many patients and too few staff.

More overtime can only worsen the problem of overwork, while an expectation of more weekend work could hit recruitment targets. And when it comes to making the NHS an attractive place to work, Labour’s plans still fall short."

I'm a longterm shareholder and have criticised the Board over many years for its lack of understanding as how to run a listed UK company.

I grant you that AIM is only a junior market and the SP can fluctuate on minimal dealings, but the main problem this time around was when the directors 'topped up' their respective shareholdings with minuscule additions.

Frankly it was pathetic for them to buy a couple of thousand shares in October 23. What was the point and what were they trying to convey to shareholders?

Such paltry additions to their existing and in some cases, substantial holdings, hardly gives us PIs the impression that they are buying because the SP is now outrageously cheap.

If they had thought so, they would have "filled their boots" with more stock, as it came onto the market.

And our brokers don't appear to have enough confidence in TLY to recommend their clients to invest here. It wouldn't take many of them to buy and stabilise the SP.

I agree with the comments already made, that the timing of this latest RNS was bizarre in the extreme - couldn't see the point of it and seems to have done more harm than good.

And presumably this was all done having first discussed it with the Company's brokers.

Having personally served on the Board of a UK listed company, it gives me no pleasure stating that this Board appears to be out of its depth, when trying to keep shareholders informed and to remain invested here.

No new contracts have been announced for some time and nothing exciting seems to be on the cards in the short term - just more of the same boring irregular meaningless announcements,

Regrettably, this latest and unexpected RNS has resulted in small sell-offs, which have themselves triggered disproportionate falls in the SP from disenchanted investors.

My suggestion to the Board: - Run it like you really care about your shareholders, or sell out for a decent value.

GLA

TG2D - Thanks for your advice over these past weeks, but I think I'll stick with Mr Buffet's.....

"

If past history was all there was to the game, the richest people would be librarians.

"

GLA

TG2D - You can postulate as much as you like about why Sneller sold out, but as always with you, it is pure speculation.

On what basis is he an 'insider'? He sees the same presentations as the rest of us and I doubt that the Board gives him any privileged information.

Frankly, he could have taken a (costly) opportunity to crystallise losses to offset a potential CGT liability on something else. There you go, I'm speculating now!

Just move on....(to another BB, hopefully??).

TG2D - Hmm! See you've only been around here since July 2023. Also note you post about ANG, where share price down in 18 months (from 150p to 13p). Lost money there, too? Ouch!

GLA

I'll give TG2D his / her due. Has done a great job in talking down TLY over recent weeks.

I've seen the recent presentation and unless the Board is lying through its teeth (and I don't think that for one second), shareholders are told that the second half year (which is already one third of the way through) will show positive cash flow - I take that to be a sign of a return to profitability. TLY also has an untapped 2.5m bank facility and we are assured there is no intention of calling on shareholders for funds - I take that as being within the next 12 months.

Slow take up of NHS tenders appears to be due to lack of money in many NHS trusts leading to the NHS slowly falling apart. No political party will be allowed to let the NHS slide into oblivion - a combination of public finds and private sector money is the only rational answer.

I repeat the wise words of investment guru, Warren Buffett: "Price is what you pay, value is what you get".

Company still paid out a final dividend of £250,000 in October AFTER knowing the half year results to 30 September 23.

If they were considering a potential rights issue, the Board could have conserved cash by cancelling the dividend, but they did not.

Perhaps TLY's Board know a little bit more about the company's short term prospects, which may be somewhat rosier than the miserable soothsayers on this BB are predicting?

No point in speculating, just ask the question at tomorrow's presentation.

GLA

Not 'totally' convinced (forgive the pun) that all these recent buys are necessarily closing out short positions.

If last year is anything to go by, interim results are due on 14 November - so, next Tuesday....?

GLA

How ITX can help in cosmetics industry :

https://news.sky.com/video/share-12978435

GLA

In the past, I have been critical of the chasm between the fantastic products being developed by ITX and its Board capability to convert undoubted potential into profits. After all, at the end of the day, that is the reason why shareholders entrust their funds to the Board.

I don't think the subject of Board incentives has been discussed before.

According to the 2022 Annual Accounts , JS received a bonus on 40 per cent on his basic salary - this compared with a 7.5 per cent bonus in the previous year. Also, LD (not a Director in the previous year) received a bonus which doubled her basic salary in 2022. These bonuses were voted through by the two non-executive Directors on the Board - presumably, the bonuses were well-deserved, but how they were calculated remains undisclosed to shareholders - it is unlikely that the bonuses were related to a small reduction in trading losses.

Furthermore, the employee share option scheme is not related to profit performance either, which for potential US investors would (I suggest) be a big negative.

US investors like stock (share) options to be linked to profit performance and/or share price performance in any given year. I wonder if this is partly why there appears to be a general lack of interest from over the pond, since the share consolidation?

Finally, on page 53 of the 2022 Annual Accounts there is a substantive paragraph under the heading 'Share Based Payments'. If anyone can understand what this actually means, I and no doubt other fellow shareholders, would like to know in layman's language.

GLA

Smart - totally my sentiments, too!

The share price will continue to drift (IMOH) on no positive news - that's how the market works. The presentation earlier in the month is now long forgotten and the market has not been impressed.

More importantly, potential US investors have kept away for the time being.

If you ask the MM for a price spread today, it will be provided based on whether you are considered a buyer, or a seller. Almost certainly, it will currently be assumed you are a seller and the sale price in the spread will reflect that.

The good news is that the SP is underpinned by cash equivalent of about 80 pence per share. So that is probably the default price until something exciting happens.

All the Board has to do is report some positive news, which indicates long-term profitability - until then it's fingers crossed and we LTHs will have to lock this investment in a very dark cupboard.

GLA

FoolsG...... With respect, you're not right here. As always, the devil is in the detail - the cash flow statement.

The reported loss in H1(23) was definitely reduced to $0.7m compared with loss H1(22) $1.1m and loss H2(22) of $1.3m. Note however, that the $0.7m loss was partly financed by a fortuitous US currency gain of $0.44m. That is an enormous differential for a six month period where gross revenues were only $4m.

If we keep on recording massive currency gains, perhaps there is something wrong with the exchange rate which ITX applies to its sterling equivalent.

Don't know where you get your info of two months in HI(23) breaking even??

GLA

No amount of snippets on this BB as to the number of contributions ITX products make to different branded products will make up for a marked absence of RNSs indicating that our Company can convert sales opportunities into desperately-needed signs of profitability.

As I have said before as a VERY longterm investor, the MMs aren't stupid - they know that without regular RNSs from the Board, the trend in share trades are only going one-way - SALES!!

Since the much-heralded share consolidation in August @ 204p, the SP has continued to drift, having lost a further 20 per cent of its market cap - this despite a positive Board presentation earlier this month. Yet, our Board seems unconcerned.

You only have to look at the SP movement, which is regrettably and inexorably on a downward path - the sale of just a few shares seems to send it lower.

Why would potential investors want to put their money here currently, when the Board offers no guidance as to when the Company will be in profit?

The longer the Company fails to get to breakeven level, the more its successful $11.5m fundraise will have to be used to shore up continuing losses. None of us signed up to that!

History suggests that the next RNS (2023 final results) will not be until June 2024 - that's NINE MONTHS away. If there is no positive news in the interim.............????

Come on, our Board - think of your fellow investors for a change....

GLA

Radium - your quote on TRMR - 21 August 2021, when TRMR share price was 818p (now trade@ 156p):

"Without a doubt, Tremor has just provided a very robust Q2 /1H earnings report and the accompanying forward looking statement points to another equally solid report in November. We then enter what is traditionally the most profitable final qtr of our fiscal year. I fully expect that the next two earnings calls will push the US and UK brokers into making substantial upgrades for Tremor, for 2022/3. That’s where I have set my horizon. Take the slightly longer view, that at least, is where I stand. I always preferred the slowly, slowly to the spikey, spikey. "

Frankly, you and STT deserve each other.... Both of you just grow up!

It's all very well using this BB to reveal what commercial brands are incorporating ITX products, but it does nothing to convince the market, that ITX is a good place for investors to place their money.

The problem is that ITX is on AIM, one of the most manipulative and unattractive markets to be quoted on. For the sale today of half a dozen shares to influence the SP by 5 per cent, says it all!

The consolidation (albeit only one week old) has done nothing to attract US investors, as was mooted beforehand. No doubt time will tell on this strategy.

As a significant holder here, I hope there isn't going to be a second consolidation of 2:1, should the SP halve to 100p!!

IMHO, our Board needs to maintain investor interest by keeping shareholders fully informed on all REAL progress being made, other than the mandatory RNS announcing trading results every six months.

On the other hand, perhaps there's nothing to announce and that may be the problem here.

I've said it before - ITX appears to be a company with fantastic green products run by a group of non-commercial professionals with total disregard for the interests of its shareholders.

Just saying... and GLA

The Newlands family appears to have had enough and one would assume they will be disposing of their entire holding on any upward trend in the current SP.

I can't see any medium term improvement in the SP until this large overhang of shares are cleared from the market.

It's a shame really, because the SP is not a fair reflection of the Company's massive potential with the various strikes gradually coming to an end, IMHO.

TwoGood - I disagree with your point re wafer-thin margins.

The company is moving from total reliance on Urgent Care (current year now 73 per cent of total revenue and down from 85 per cent in 2022).

The more profitable Elective Care (EC) business now represents 26 per cent of total revenue (up from 14 per cent in 2022).

Also EC profit margin(@ 19. 8 per cent is 2.2 per cent higher than Urgent Care (@ 17.6 pr cent).

So higher margin business on a division which now accounts for over 26 per cent of total revenues indicates TLY going in the right direction and no longer a one trip pony.

My main criticism is that the final dividend should not have been declared at this time - in order to conserve cash during these challenging times.

Foolhardy in my view and the market has voted with its feet on this irrational decision (IMHO). Perhaps the CEO will explain why, later this morning.

GLA